Dolby Laboratories, Inc. — Specialty Business Services. Scored on the same transparent 7-signal model behind the daily rankings.
★
DLB
Dolby Laboratories, Inc. · Specialty Business Services
FCF$258mC
Rev+5.9%C+
D/E0.02A
P/E19.9xB+
PEG1.29B
72.3Score
$50.12$4.7B
1Y Target$78.33Analyst consensus · 3 analysts
5Y Target$114.69Compound horizon
10Y Target$170.13Long-dated conviction
FCF$258mTTM · 03/26C
FCF $258m — modest; watch for margin expansion · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+5.9%FY YoYC+
Revenue +5.9% — steady but below market-beating range · Computed from last two annual revenue figures (FY YoY).
D/E0.02A
D/E 0.02 — least levered decile in Industrials (≈10th pctile)
P/E19.9xB+
P/E 19.9 — below the Industrials median (≈40th pctile)
PEG1.29B
PEG 1.29 — acceptable premium for growth
Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.
Quality-growth score · 72.3
Quality0.73
Growth0.65
Value0.79
Why this score
Raising its dividend
Entry · Margin of safety
52-week rangeNear 52-week low
35% off the 12-month high
vs DCF fair value2% belowest. fair value ~$51
Why now
Specialty Business Services · market cap $4.7b. Down 35% from 52-week high of $77.00 — deep drawdown territory. 3 sell-side analysts publish a mean 1-yr target of $78.33 (implying +56% upside).
Moat
Net margin 18% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. FCF converts 106% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 35% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $78.33 (3-analyst consensus) — fundamentals + valuation re-rating. 5 yr $114.69 at ~18% CAGR — compounding case rests on the competitive position widening. 10 yr $170.13 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · DLB
$
%
%
Shares to buy
39
Position size
$1,955
3.9% of portfolio
Stop price
$37.59
25% below $50.12
$ at risk if stopped
$488.67
budget $500.00 · 1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Dolby Laboratories, Inc. (DLB): score, valuation & FAQ
Dolby Laboratories, Inc. (DLB) is a Specialty Business Services company that scores 72.3 out of 100 on the Bull Rankings quality-growth model — a solid, above-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are D/E (A) and P/E (B+). On valuation, DLB sits close to our DCF fair-value estimate (within a few percent).
Is DLB a good stock to buy?
Bull Rankings scores DLB 72.3 out of 100 on its quality-growth model, which is a solid, above-average reading. That is driven by D/E (A) and P/E (B+). A score is a quantitative screen of Dolby Laboratories, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does DLB score 72.3 on Bull Rankings?
The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). DLB earns its highest marks on D/E (A) and P/E (B+). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.
Is DLB overvalued or undervalued?
Based on $50.12, DLB sits close to our DCF fair-value estimate (within a few percent). It trades at a 19.9x× P/E (graded B+). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in DLB?
Down 35% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial adviser.